Effect of perioperative esketamine administration on the incidence of postoperative delirium: a systematic review and meta-analysis

Postoperative delirium (POD) is a common neurocognitive complication following surgery, particularly in older adults. Esketamine has been investigated for potential neuroprotective effects in the perioperative setting. This systematic review and meta-analysis aimed to evaluate the effect of perioperative esketamine on the incidence of POD. A comprehensive literature search was conducted across multiple electronic databases (PubMed, Cochrane Library, EMBASE, and Google Scholar) to identify randomized controlled trials (RCTs) evaluating the association between perioperative esketamine administration and POD. The primary outcome was the incidence of POD. Secondary outcomes included postoperative cognitive dysfunction (POCD), delayed neurocognitive recovery (dNCR), postoperative nausea and vomiting (PONV), length of hospital stay, length of post-anesthesia care unit (PACU) stay, and postoperative pain in the first 24 h after surgery. PROSPERO registration: CRD42024587392. 25 RCTs involving 3,669 participants were included (esketamine: 17 trials; ketamine: 8 trials). Esketamine was associated with a lower incidence of POD (risk ratio [RR]: 0.55, 95% confidence interval [CI]: 0.46–0.67, P < 0.00001), whereas ketamine showed no significant effect (RR: 0.64, 95% CI: 0.32–1.29, P = 0.21). Results were consistent in studies enrolling elderly patients (≥ 65 years) (RR: 0.57, 95% CI: 0.41–0.80, P = 0.001). Esketamine was also associated with a lower risk of PONV and reduced pain within 24 h after surgery. No significant differences were observed in hospital or PACU length of stay. Perioperative administration of esketamine was associated with significantly lower incidence of POD, without concomitant increases in length of hospital or PACU stay. 1. Perioperative administration of esketamine was associated with significantly reduced incidence of postoperative delirium. 2. Secondary analysis demonstrated that ketamine administration was not associated with a significant reduction in the incidence of postoperative delirium. 3. Our study revealed no significant increase in hospital or post-anesthesia care unit stay associated with esketamine use.

Authors

Institutions

Publication Details

Journal
BMC Anesthesiology
Published
2026-04-01
DOI
https://doi.org/10.1186/s12871-026-03785-0
Primary Topic
Intensive Care Unit Cognitive Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of perioperative esketamine administration on the incidence of postoperative delirium: a systematic review and meta-analysis

Xiaoye Liu, Xuemiao Tang, Qiuhua He, Qiang Fu et al.
BMC Anesthesiology
Intensive Care Unit Cognitive Disorders
article

Effect of perioperative esketamine administration on the incidence of postoperative delirium: a systematic review and meta-analysis

Xiaoye Liu, Xuemiao Tang, Qiuhua He, Qiang Fu, Gang Luo
article en

Abstract

Postoperative delirium (POD) is a common neurocognitive complication following surgery, particularly in older adults. Esketamine has been investigated for potential neuroprotective effects in the perioperative setting. This systematic review and meta-analysis aimed to evaluate the effect of perioperative esketamine on the incidence of POD. A comprehensive literature search was conducted across multiple electronic databases (PubMed, Cochrane Library, EMBASE, and Google Scholar) to identify randomized controlled trials (RCTs) evaluating the association between perioperative esketamine administration and POD. The primary outcome was the incidence of POD. Secondary outcomes included postoperative cognitive dysfunction (POCD), delayed neurocognitive recovery (dNCR), postoperative nausea and vomiting (PONV), length of hospital stay, length of post-anesthesia care unit (PACU) stay, and postoperative pain in the first 24 h after surgery. PROSPERO registration: CRD42024587392. 25 RCTs involving 3,669 participants were included (esketamine: 17 trials; ketamine: 8 trials). Esketamine was associated with a lower incidence of POD (risk ratio [RR]: 0.55, 95% confidence interval [CI]: 0.46–0.67, P < 0.00001), whereas ketamine showed no significant effect (RR: 0.64, 95% CI: 0.32–1.29, P = 0.21). Results were consistent in studies enrolling elderly patients (≥ 65 years) (RR: 0.57, 95% CI: 0.41–0.80, P = 0.001). Esketamine was also associated with a lower risk of PONV and reduced pain within 24 h after surgery. No significant differences were observed in hospital or PACU length of stay. Perioperative administration of esketamine was associated with significantly lower incidence of POD, without concomitant increases in length of hospital or PACU stay. 1. Perioperative administration of esketamine was associated with significantly reduced incidence of postoperative delirium. 2. Secondary analysis demonstrated that ketamine administration was not associated with a significant reduction in the incidence of postoperative delirium. 3. Our study revealed no significant increase in hospital or post-anesthesia care unit stay associated with esketamine use.

BMC Anesthesiology
Third People's Hospital of Chengdu (CN), Macao Polytechnic University (MO)
Good health and well-being
Openalex Percentile: Top 30%
Intensive Care Unit Cognitive Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.